Clinical Trials Details

EA1181 CompassHER2-pCR (Breast)

Preoperative THP and postoperative HP in patients who achieve a pathologic complete response. Part 1 Component of: The CompassHER2 Trials (COMprehensive use of Pathologic response ASSessment to optimize therapy in HER2-positive breast cancer

Clinical Trial Categories

  • Cancers and Other Neoplasms